Tapewire

Nasdaq · USD

CYPH

CYPHERPUNK TECHNOLOGIES INC.

Export transactions ↓
Tapewire entity
6392
SEC CIK
0001509745
Parsed reports
291

Last 12 months

Inside the activity.

0 purchase rows · 9 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2024 Filed Feb 1, 2024 02:37 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009031 · tm244775-15_4seq1.xml · derivative · entry 1

Mashiach Nissim · CIK 0001357777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:36 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009030 · tm244775-8_4seq1.xml · derivative · entry 1

Dietz Thomas John · CIK 0001574218 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:36 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009029 · tm244775-14_4seq1.xml · derivative · entry 1

Schilsky Richard · CIK 0001945662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:35 UTC
Baum JasonChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 85,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009027 · tm244775-6_4seq1.xml · derivative · entry 1

Baum Jason · CIK 0001970907 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Common Stock · 85,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of January 29, 2024.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:35 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009026 · tm244775-13_4seq1.xml · derivative · entry 1

Richard Christian M · CIK 0001645967 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:34 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.68 $0.00
Disclosure

SEC source: 0001104659-24-009023 · tm244775-12_4seq1.xml · derivative · entry 1

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-01-29

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:39 UTC
Sirard CynthiaChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-008419 · tm244628-3_4seq1.xml · derivative · entry 2

Sirard Cynthia · CIK 0001808408 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:39 UTC
Sirard CynthiaChief Medical Officer
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-008419 · tm244628-3_4seq1.xml · nonDerivative · entry 1

Sirard Cynthia · CIK 0001808408 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:41 UTC
O'Mahony John MarkChief Manufacturing Officer
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-008420 · tm244628-4_4seq1.xml · derivative · entry 2

O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:41 UTC
O'Mahony John MarkChief Manufacturing Officer
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-008420 · tm244628-4_4seq1.xml · nonDerivative · entry 1

O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.

Read SEC document
January 26, 2024 Filed Jan 31, 2024 01:37 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
Exercise / conversionRestricted Stock Units · Derivative 7,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-008417 · tm244628-1_4seq1.xml · derivative · entry 3

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
January 26, 2024 Filed Jan 31, 2024 01:37 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
Exercise / conversionCommon Stock 7,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-008417 · tm244628-1_4seq1.xml · nonDerivative · entry 1

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,646

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:42 UTC
Mirabelli ChristopherDirector · Chairman of the Board
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-008421 · tm244628-5_4seq1.xml · derivative · entry 3

Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 20:42 UTC
Mirabelli ChristopherDirector · Chairman of the Board
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-008421 · tm244628-5_4seq1.xml · nonDerivative · entry 1

Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.

Read SEC document
January 26, 2024 Filed Jan 31, 2024 01:38 UTC
LAWLOR AUGUSTINEChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-008418 · tm244628-2_4seq1.xml · derivative · entry 4

LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
January 26, 2024 Filed Jan 31, 2024 01:38 UTC
LAWLOR AUGUSTINEChief Operating Officer
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-008418 · tm244628-2_4seq1.xml · nonDerivative · entry 1

LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,086

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 16:30 UTC
Granfield ChristineVP, Head of Reg Affairs/Qual
GrantEmployee Stock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095369 · tm2324823-15_4seq1.xml · derivative · entry 1

Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 16:30 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095360 · tm2324823-6_4seq1.xml · derivative · entry 1

CAVANAUGH JAMES H · CIK 0001013473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 16:30 UTC
Sirard CynthiaChief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095366 · tm2324823-12_4seq1.xml · derivative · entry 1

Sirard Cynthia · CIK 0001808408 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 16:30 UTC
O'Mahony John MarkChief Manufacturing Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095367 · tm2324823-13_4seq1.xml · derivative · entry 1

O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC
LI WILLIAMDirector
GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095362 · tm2324823-8_4seq1.xml · derivative · entry 1

LI WILLIAM · CIK 0001273806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:30 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
GrantEmployee Stock Option (Right to Buy) · Derivative 140,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095363 · tm2324823-9_4seq1.xml · derivative · entry 1

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC
LAWLOR AUGUSTINEChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095365 · tm2324823-11_4seq1.xml · derivative · entry 1

LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 16:31 UTC
Mirabelli ChristopherDirector · Chairman of the Board
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095364 · tm2324823-10_4seq1.xml · derivative · entry 1

Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:30 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095359 · tm2324823-5_4seq1.xml · derivative · entry 1

LOSCALZO JOSEPH · CIK 0001276128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095357 · tm2324823-3_4seq1.xml · derivative · entry 1

Mashiach Nissim · CIK 0001357777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095361 · tm2324823-7_4seq1.xml · derivative · entry 1

Dietz Thomas John · CIK 0001574218 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095358 · tm2324823-4_4seq1.xml · derivative · entry 1

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:31 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095356 · tm2324823-2_4seq1.xml · derivative · entry 1

Richard Christian M · CIK 0001645967 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:30 UTC GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095355 · tm2324823-1_4seq1.xml · derivative · entry 1

Schilsky Richard · CIK 0001945662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Read SEC document
August 23, 2023 Filed Aug 25, 2023 20:30 UTC
Baum JasonChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $2.21 $0.00
Disclosure

SEC source: 0001104659-23-095368 · tm2324823-14_4seq1.xml · derivative · entry 1

Baum Jason · CIK 0001970907 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2033-08-23

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:15 UTC
Granfield ChristineVP, Head of Reg Affairs/Qual
GrantEmployee Stock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041752 · tm2311741-11_4seq1.xml · derivative · entry 1

Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:14 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041749 · tm2311741-8_4seq1.xml · derivative · entry 1

CAVANAUGH JAMES H · CIK 0001013473 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:17 UTC
Sirard CynthiaChief Medical Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041754 · tm2311741-14_4seq1.xml · derivative · entry 1

Sirard Cynthia · CIK 0001808408 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:17 UTC
O'Mahony John MarkChief Manufacturing Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041753 · tm2311741-13_4seq1.xml · derivative · entry 1

O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:14 UTC
LI WILLIAMDirector
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041750 · tm2311741-9_4seq1.xml · derivative · entry 1

LI WILLIAM · CIK 0001273806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:10 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
GrantEmployee Stock Option (Right to Buy) · Derivative 750,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041743 · tm2311741-2_4seq1.xml · derivative · entry 1

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:09 UTC
LAWLOR AUGUSTINEChief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041741 · tm2311741-1_4seq1.xml · derivative · entry 1

LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 20:18 UTC GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041755 · tm2311741-12_4seq1.xml · derivative · entry 1

Mirabelli Christopher · CIK 0001262326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:15 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041751 · tm2311741-10_4seq1.xml · derivative · entry 1

LOSCALZO JOSEPH · CIK 0001276128 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:11 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041744 · tm2311741-3_4seq1.xml · derivative · entry 1

Mashiach Nissim · CIK 0001357777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:13 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041748 · tm2311741-7_4seq1.xml · derivative · entry 1

Schilsky Richard · CIK 0001945662 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:12 UTC GrantStock Option (Right to Buy) · Derivative 175,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041747 · tm2311741-6_4seq1.xml · derivative · entry 1

Dietz Thomas John · CIK 0001574218 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:12 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041746 · tm2311741-5_4seq1.xml · derivative · entry 1

Martin Patricia A. · CIK 0001916764 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 31, 2023 Filed Apr 5, 2023 00:11 UTC GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $0.34 $0.00
Disclosure

SEC source: 0001104659-23-041745 · tm2311741-4_4seq1.xml · derivative · entry 1

Richard Christian M · CIK 0001645967 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-03-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.

Read SEC document
March 17, 2023 Filed Mar 21, 2023 20:05 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
Exercise / conversionRestricted Stock Units · Derivative 660,606 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-035047 · tm2310117-1_4seq1.xml · derivative · entry 3

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 660,606 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: On March 17, 2020, the reporting person was granted 660,606 Restricted Stock Units, vesting on March 17, 2023 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

F3 · derivative.expiration_date: On March 17, 2020, the reporting person was granted 660,606 Restricted Stock Units, vesting on March 17, 2023 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.

Read SEC document
March 17, 2023 Filed Mar 21, 2023 20:05 UTC
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
Exercise / conversionCommon Stock 660,606 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-035047 · tm2310117-1_4seq1.xml · nonDerivative · entry 1

ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 661,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis.

Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:35 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $1.62 $0.00
Disclosure

SEC source: 0001104659-22-098627 · tm2225478-2_4seq1.xml · derivative · entry 1

Schilsky Richard · CIK 0001945662 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2032-09-06

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of equal quarterly installments for 12 quarters, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.

Read SEC document
September 01, 2022 Filed Sep 2, 2022 21:29 UTC
Granfield ChristineVP, Head of Reg Affairs/Qual
GrantEmployee Stock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001104659-22-097622 · tm2225099-11_4seq1.xml · derivative · entry 1

Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date.

Read SEC document
September 01, 2022 Filed Sep 2, 2022 21:41 UTC GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001104659-22-097623 · tm2225099-4_4seq1.xml · derivative · entry 1

CAVANAUGH JAMES H · CIK 0001013473 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-08-31

F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.